Talking Euretina

When is it time to stop treating radiation maculopathy? Dr Lara Sandri (Johannesburg) and Dr Rodrigo Anguita (Moorfields Eye Hospital, London) share their highlights from the Euretina Congress in Vienna, from a five-phase model of radiation damage and the genetics that separate uveal from skin melanoma, to predicting proliferative vitreoretinopathy before it takes hold and how regulators will judge AI. The sessions are available to watch on demand.

Can a macular hole close without a gas bubble? Dr Stratos Gotzaridis and Dr Elise Philippakis share their highlights from Euretina 2026 in Vienna: a buckle placed without sutures, the unresolved debate over myopic traction maculopathy, and why myopia is no longer just a retina problem.

Ask ten surgeons which tamponade to use in retinal detachment repair and you will get ten different answers. Ahead of his Ingrid Kreissig Lecture at the Euretina Congress in Vienna, Prof. David Steel joins Prof. Jens Kiilgaard to ask why the evidence base is still so thin, what our gases really cost the environment, and why he believes a revolution in tamponades is coming.

Ahead of his Ophthalmologica Lecture at the Euretina Congress in Vienna, Dr. Elon van Dijk joins Ophthalmologica Editor-in-Chief Prof. Martin Zinkernagel to explain why central serous chorioretinopathy remains so hard to pin down — and what multimodal imaging can tell us about which eyes will resolve on their own. They discuss the evidence behind half-dose PDT, the trials that got us there, and the career choices behind the lecture

Ahead of her Gisbert Richard Lecture at the Euretina Congress in Vienna, Prof. Noemi Lois tells Prof. Nicole Eter why diabetic tractional retinal detachment is far more than a mechanical problem — and why we may be catching patients too late. They discuss the scarce evidence on risk factors, anti-VEGF before vitrectomy, tamponade choices, and what the EMERALD study means for clinic capacity